You are here: Home » PTI Stories » National » News
Business Standard

Dr Reddy's gets EIR for Hyderabad facility

Press Trust of India  |  New Delhi 

Drug firm Dr Reddy's Laboratories today said it has received establishment inspection report (EIR) from the US health regulator for its custom pharmaceutical services facility at

The facility had undergone audit by the United States Food and Drug Administration (USFDA), Dr Reddy's Laboratories said in a filing.

The company has received EIR from the USFDA for the facility, it added.

As per USFDA, after the completion of an inspection of a facility, an EIR is issued to a company detailing inspection findings.

of Dr Reddy's Laboratories today closed at Rs 2,230.45 per scrip on BSE, down 2.44 per cent.

(This story has not been edited by Business Standard staff and is auto-generated from a syndicated feed.)

First Published: Fri, December 01 2017. 19:10 IST